The primary responsibility of the Biomechanics Core is to provide more consistent and comparable experimental models of gray matter (mouse controlled cortical impact), white matter (inertial injury in minipig, mouse optic nerve stretch), and mixed (rat lateral fluid percussion) traumatic brain injury. Our overall hypotheses for the core activities are (1) primary axonal damage is related to the tensile strain directed along the neural tracts during injury (3) injury thresholds for primary neuronal vascular, and axonal pathologies are constant across species (4) physical differences in the tissue, skull, and brain geometry across species and strains within a species can affect the injury pattern caused by a mechanical insult. The specific responsibilities of this core are: Responsibility 1: To develop and rigorously validate biomechanical models of the cortical impact technique for producing predominantly gray matter injury of programmable severity in the mouse. Responsibility 2: To use biomechanical modeling tools to correlate immunohistochemical markers for axonal damage (NF68, APP), cytoskeletal changes (SBP), and neurodegeneration (Abeta) that occur in the inertial injury in the miniature pig. Responsibility 3: Provide a model of white matter injury in the mouse optic nerve that consistently produces axonal damage in the nerve at a fixed stretch level (Year 1) an can be adjusted to provide more mild or severe levels of axonal damage (Years 2-3). Responsibility 4: Formulate, validate, and apply microstructure and molecular based models of material behavior to study the white matter (diffuse) injury models. By focusing on these responsibilities, we expect to achieve consistent and reproducible models of an injury specific pathology, understand the transfer of these models across species, and develop validated mathematical descriptions for the transfer of bulk stress and strain to the cell and molecular level. Once accomplished, the core activities will provide more powerful and standardized models to study the mechanisms, molecular sequelae, and treatment of the brain injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS008803-28A2
Application #
6358994
Study Section
Project Start
2000-09-30
Project End
2001-08-31
Budget Start
Budget End
Support Year
28
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Nariai, Hiroki; Duberstein, Susan; Shinnar, Shlomo (2018) Treatment of Epileptic Encephalopathies: Current State of the Art. J Child Neurol 33:41-54
Nariai, Hiroki; Beal, Jules; Galanopoulou, Aristea S et al. (2017) Scalp EEG Ictal gamma and beta activity during infantile spasms: Evidence of focality. Epilepsia 58:882-892
Tomasevic, Gregor; Laurer, Helmut L; Mattiasson, Gustav et al. (2012) Delayed neuromotor recovery and increased memory acquisition dysfunction following experimental brain trauma in mice lacking the DNA repair gene XPA. J Neurosurg 116:1368-78
Browne, Kevin D; Chen, Xiao-Han; Meaney, David F et al. (2011) Mild traumatic brain injury and diffuse axonal injury in swine. J Neurotrauma 28:1747-55
Tomasevic, Gregor; Raghupathi, Ramesh; Scherbel, Uwe et al. (2010) Deletion of the p53 tumor suppressor gene improves neuromotor function but does not attenuate regional neuronal cell loss following experimental brain trauma in mice. J Neurosci Res 88:3414-23
Hånell, Anders; Clausen, Fredrik; Björk, Maria et al. (2010) Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 27:1297-309
Marklund, N; Morales, D; Clausen, F et al. (2009) Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience 163:540-51
Marklund, Niklas; Bareyre, Florence M; Royo, Nicolas C et al. (2007) Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg 107:844-53
Keck, Carrie A; Thompson, Hilaire J; Pitkanen, Asla et al. (2007) The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury. Restor Neurol Neurosci 25:77-90
Serbest, Gulyeter; Burkhardt, Matthew F; Siman, Robert et al. (2007) Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice. Neurochem Res 32:2006-14

Showing the most recent 10 out of 71 publications